Author:
Mengozzi Alessandro, ,Georgiopoulos Georgios,Falcone Marco,Tiseo Giusy,Pugliese Nicola Riccardo,Dimopoulos Meletios A.,Ghiadoni Lorenzo,Barbieri Greta,Forfori Francesco,Carrozzi Laura,Santini Massimo,Monzani Fabio,De Marco Salvatore,Menichetti Francesco,Virdis Agostino,Masi Stefano
Abstract
AbstractHigh sensitivity troponin T (hsTnT) is a strong predictor of adverse outcome during SARS-CoV-2 infection. However, its determinants remain partially unknown. We aimed to assess the relationship between severity of inflammatory response/coagulation abnormalities and hsTnT in Coronavirus Disease 2019 (COVID-19). We then explored the relevance of these pathways in defining mortality and complications risk and the potential effects of the treatments to attenuate such risk. In this single-center, prospective, observational study we enrolled 266 consecutive patients hospitalized for SARS-CoV-2 pneumonia. Primary endpoint was in-hospital COVID-19 mortality. hsTnT, even after adjustment for confounders, was associated with mortality. D-dimer and CRP presented stronger associations with hsTnT than PaO2. Changes of hsTnT, D-dimer and CRP were related; but only D-dimer was associated with mortality. Moreover, low molecular weight heparin showed attenuation of the mortality in the whole population, particularly in subjects with higher hsTnT. D-dimer possessed a strong relationship with hsTnT and mortality. Anticoagulation treatment showed greater benefits with regard to mortality. These findings suggest a major role of SARS-CoV-2 coagulopathy in hsTnT elevation and its related mortality in COVID-19. A better understanding of the mechanisms related to COVID-19 might pave the way to therapy tailoring in these high-risk individuals.
Publisher
Springer Science and Business Media LLC
Reference28 articles.
1. Guo, T. et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (Covid-19). JAMA Cardiol. 2, 10 (2020).
2. Shi, S. et al. Association of cardiac injury with mortality in hospitalized patients with covid-19 in Wuhan China. JAMA Cardiol. 5, 964 (2020).
3. Zhou, F. et al. Clinical course and risk factors for mortality of adult inpatients with covid-19 in Wuhan, China: a retrospective cohort study. Lancet 395, 1054–1062 (2020).
4. Ar, C., Bularga, A. & Nl, M. High-sensitivity cardiac troponin can be an ally in the fight against covid-19. Circulation 3, 116 (2020).
5. Zheng, Y., Ma, Y., Zhang, J. & Xie, X. Covid-19 and the cardiovascular system. Nat. Rev. Cardiol. 17, 259–260 (2020).
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献